Login / Signup

HEIDI: an experiment-management platform enabling high-throughput fragment and compound screening.

A MetzD P StegmannE H PanepucciS BuehlmannChia Yiang HuangKatherine Evelyn McAuleyMeitian WangJustyna Aleksandra WojdylaM E SharpeKate Mary Louise Smith
Published in: Acta crystallographica. Section D, Structural biology (2024)
The Swiss Light Source facilitates fragment-based drug-discovery campaigns for academic and industrial users through the Fast Fragment and Compound Screening (FFCS) software suite. This framework is further enriched by the option to utilize the Smart Digital User (SDU) software for automated data collection across the PXI, PXII and PXIII beamlines. In this work, the newly developed HEIDI webpage (https://heidi.psi.ch) is introduced: a platform crafted using state-of-the-art software architecture and web technologies for sample management of rotational data experiments. The HEIDI webpage features a data-review tab for enhanced result visualization and provides programmatic access through a representational state transfer application programming interface (REST API). The migration of the local FFCS MongoDB instance to the cloud is highlighted and detailed. This transition ensures secure, encrypted and consistently accessible data through a robust and reliable REST API tailored for the FFCS software suite. Collectively, these advancements not only significantly elevate the user experience, but also pave the way for future expansions and improvements in the capabilities of the system.
Keyphrases
  • high throughput
  • data analysis
  • electronic health record
  • big data
  • drug discovery
  • machine learning
  • wastewater treatment
  • deep learning